Clinical Trials

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

Location:

Rochester,  MN

Trial status:

Open for Enrollment

Why is this study being done?

This study is an extension protocol for study A3051123. No treatment is provided during this study. This study is to monitor for cardiovascular events 28 weeks after completion of A3051123. This study is an extension protocol for study A3051123. No treatment is provided during this study. This study is to monitor for cardiovascular events 28 weeks after completion of A3051123.

Who is eligible to participate?

Inclusion Criteria:

- Subjects will be eligible if they were randomized to study A3051123.

Exclusion Criteria:

- Participation in study A3051123 ceased (ie, withdrew consent, lost to follow-up, etc) prior to final visit of study A3051123.

Last updated: 05/01/2013

NCT ID:

NCT01574703